Parkinsonism in HIV infected patients during antiretroviral therapy – data from a Brazilian tertiary hospital
AUTOR(ES)
Dehner, Luis Filipe, Spitz, Mariana, Pereira, João Santos
FONTE
Braz J Infect Dis
DATA DE PUBLICAÇÃO
2016-10
RESUMO
Abstract Introduction Advances in the treatment of HIV infection in the last decades have increased life expectancy of these patients and raise the question of what kind of effect chronic infection and its treatment might exert on the behavior of age-related conditions such as neurodegenerative diseases. Patient data We performed a retrospective analysis of patients’ records to assess the frequency of the association between HIV infection and parkinsonian symptoms in our hospital population. Among 249 records we identified four individuals with reported parkinsonian symptoms initiated after HIV diagnosis. Three of them had no other identifiable cause of secondary parkinsonism. All had symptom onset before the age of 60. Based on this study sample one could estimate an incidence rate of nearly 101 per 100.000 person/year, which is similar to the risk of Parkinson's disease in the general population above 70 years. Discussion These findings suggest that HIV infected individuals might be at a higher risk for developing parkinsonism as a manifestation of early neurodegeneration. Prospective and larger studies are needed to address this particular association and its characteristics.
Documentos Relacionados
- Difficulties reported by hiv-infected patients using antiretroviral therapy in brazil
- Impact of macrolide therapy on mortality of HIV-infected patients with community-acquired pneumonia in a tertiary teaching hospital
- Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America
- Clinical forms and outcome of tuberculosis in HIV-infected patients in a tertiary hospital in São Paulo - Brazil
- Adherence to antiretroviral therapy of Brazilian HIV-infected children and their caregivers